These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10639000)

  • 1. The history of inhibitors of angiotensin converting enzyme.
    Vane JR
    J Physiol Pharmacol; 1999 Dec; 50(4):489-98. PubMed ID: 10639000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The renin-angiotensin system--from Tigerstedt to Goldblatt to ACE inhibition and beyond.
    Atlas SA; Rosendorff C
    Mt Sinai J Med; 1998 Mar; 65(2):81-6. PubMed ID: 9520510
    [No Abstract]   [Full Text] [Related]  

  • 3. From CONSENSUS to SAVE: The Early Development of Inhibition of the Renin-Angiotensin System in the Treatment of Chronic Heart Failure.
    Swedberg K
    J Card Fail; 2016 May; 22(5):395-8. PubMed ID: 26616579
    [No Abstract]   [Full Text] [Related]  

  • 4. Sir John Robert Vane: 29 March 1927 - 19 November 2004.
    Moncada S
    Biogr Mem Fellows R Soc; 2006; 52():401-11. PubMed ID: 18551797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects. 1981.
    Brunner DB; Desponds G; Biollaz J; Keller I; Ferber F; Gavras H; Brunner HR; Schelling JL
    Br J Clin Pharmacol; 2004 Dec; 58(7):S778-84; discussion S785-7. PubMed ID: 15595971
    [No Abstract]   [Full Text] [Related]  

  • 6. Victor Dzau MD.
    Eur Heart J; 2016 Sep; 37(34):2618-9. PubMed ID: 27655651
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of angiotensin-converting enzyme inhibitors in vascular modulation: beyond the hypertensive effects.
    Katragadda S; Arora RR
    Am J Ther; 2010; 17(1):e11-23. PubMed ID: 20090429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The renin-angiotensin system and angiotensin converting enzyme (ACE) inhibitors.
    Kellow NH
    Anaesthesia; 1994 Jul; 49(7):613-22. PubMed ID: 8042731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of the renin-angiotensin system.
    Nicholls MG; Charles CJ; Crozier IG; Espiner EA; Ikram H; Rademaker MJ; Richards AM; Yandle TG
    J Hypertens Suppl; 1994 Dec; 12(10):S95-103. PubMed ID: 7769497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison between the effects of angiotensin-converting enzyme inhibitors and angiotensin II antagonists].
    Asmar R; Madonna O; Brisac AM; Benetos A; Laurent S
    Therapie; 1998; 53(3):253-70. PubMed ID: 9773125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of angiotensin-converting enzyme inhibitors in congestive heart failure.
    Galvao M
    Heart Lung; 1990 Sep; 19(5 Pt 1):505-11. PubMed ID: 2211159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The renin-angiotensin system and the heart: a historical review.
    Cleland SJ; Reid JL
    Heart; 1996 Nov; 76(3 Suppl 3):7-12. PubMed ID: 8977359
    [No Abstract]   [Full Text] [Related]  

  • 13. The discovery of captopril: reply.
    Gavras H
    FASEB J; 2004 Feb; 18(2):225. PubMed ID: 14769815
    [No Abstract]   [Full Text] [Related]  

  • 14. The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects.
    Falkenhahn M; Gohlke P; Paul M; Stoll M; Unger T
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S6-13. PubMed ID: 7898096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A 100-year perspective on renal function and hypertension. Anti-renin therapy has made hypertensive renal failure a rarity].
    Bergström G; Herlitz H; Himmelmann A; Ljungman S; Aurell M
    Lakartidningen; 1999 Nov; 96(47):5209-14. PubMed ID: 10608112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment with ACE inhibitors until the end of life? Cardiovascular protective mechanisms during blockade of the renin-angiotensin system].
    Werner N; Böhm M
    Dtsch Med Wochenschr; 2004 Jul; 129(27):1513-8. PubMed ID: 15227593
    [No Abstract]   [Full Text] [Related]  

  • 17. [What have we learned from converting enzyme inhibitors on renin-angiotensin system?].
    Waeber B; Nussberger J; Brunner HR
    Rev Prat; 1992 Dec; 42(20):2529-32. PubMed ID: 1338608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. History of the design of captopril and related inhibitors of angiotensin converting enzyme.
    Cushman DW; Ondetti MA
    Hypertension; 1991 Apr; 17(4):589-92. PubMed ID: 2013486
    [No Abstract]   [Full Text] [Related]  

  • 19. [ACE-inhibitors: physiologic premises and pharmacologic profiles].
    Marino A; Schettini G; Florio T; Ventra C
    Clin Ter; 1990 Feb; 132(4):267-76. PubMed ID: 2140314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The discovery of captopril: a reply.
    Smith CG; Vane JR
    FASEB J; 2004 Jun; 18(9):935. PubMed ID: 15173103
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.